Genitourinary Symptoms of Menopause (GSM) previously known as Atrophic Vaginitis is a chronic, progressive vulvovaginal, sexual and lower urinary tract condition. GSM mainly occurs due to lack of estrogen after onset of natural menopause, surgery or chemotherapy for certain conditions such as breast cancer. Symptoms of GSM are experienced by more than 50 percent of menopausal women.
Some of the symptoms of GSM are: vaginal dryness, itching, irritation and burning in vaginal and vulvar areas, pain during sex, bleeding and burning after sex, urinary frequency, urgency and incontinence.
Besides other treatments, laser therapy has become a treatment options for GSM. In 2014 FDA approved the use of fractional CO2 laser for gynecological surgeries. At a specific diode setting, application of this laser therapy — MonaLisa Touch® — to vaginal mucosa has been shown to improve glycogen storage, vascularity and to stimulate production of collagen and other components of tissue resulting in an increase in thickness and viability of vaginal mucosa. MonaLisa Touch® is not a vaginal rejuvenation tool or a cosmetic procedure.
What is MonaLisa Touch®?
Treatment with MonaLisa Touch® is an office procedure done in a series of three treatments, six weeks apart.
To schedule your appointment, call our office at (845) 433-0101.
Note: The information provided on this page is not intended to be used for medical diagnosis or as medical advice. This information is not comprehensive and does not recommend a course of action to be followed. For medical advice, please consult with your obstetrician and gynecologist.